Montreal, QC, Canada · Oka, QC, Canada · Nunavut, Canada · Canada, KS, USA · Tay, ON, Canada · Canada, NC, USA · Emo, ON, Canada · Emo, ON, Canada · Ayr, ON, Canada · Canada
Valence is committed to unlocking the true potential of deep learning in drug design by unifying best-in-class deep learning technologies with intuitive infrastructure to make these technologies more broadly accessible to R&D organizations of all sizes. Valence's AI-enabled drug design platform has been extensively validated and is currently being used to identify and design drug candidates in collaboration with industry-leading partners. The company is pioneering the application of few-shot learning in drug design and is developing and deploying novel machine learning methods for molecular property prediction, generative chemistry, and multiparameter optimization. Valence (formerly InVivo AI) was founded in 2018, is advised by deep learning pioneer, Dr. Yoshua Bengio, and is proudly headquartered in Montreal at Mila, the world's largest deep learning research institute, with an office in Cambridge, Mass.
Is this your company?
Something looks off?